BLISS GVS PHARMA
Back to Income Statement
|
BLISS GVS PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹770 Cr | ₹752 Cr | ₹747 Cr | ₹577 Cr | ₹689 Cr |
What is the latest Revenue of BLISS GVS PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹770 Cr |
| Mar2024 | ₹752 Cr |
| Mar2023 | ₹747 Cr |
| Mar2022 | ₹577 Cr |
| Mar2021 | ₹689 Cr |
How is Revenue of BLISS GVS PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹770 Cr | 2.48 | |
| Mar2024 | ₹752 Cr | 0.55 | |
| Mar2023 | ₹747 Cr | 29.50 | |
| Mar2022 | ₹577 Cr | -16.26 | |
| Mar2021 | ₹689 Cr | - | |
Compare Revenue of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹1,818.2 Cr | 2.7% | 5.1% | 17.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,341.0 Cr | -1.8% | -6.4% | -10.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,401.0 Cr | -0.3% | -5.5% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,175.0 Cr | -0.1% | 4% | 18.7% | Stock Analytics | |
| CIPLA | ₹107,100.0 Cr | 1% | -12.3% | -5.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,715.9 Cr | -4.6% | -7% | 1.8% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 2.7% |
5.1% |
17.3% |
| SENSEX | -1% |
-4.7% |
6% |
You may also like the below Video Courses